Page last updated: 2024-09-05

sb 203580 and Leishmaniasis, American

sb 203580 has been researched along with Leishmaniasis, American in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Awasthi, A; Boppana, R; Jain, N; Joshi, BN; Khan, A; Mathur, R; Mitra, D; Saha, B; Sawant, S1

Other Studies

1 other study(ies) available for sb 203580 and Leishmaniasis, American

ArticleYear
CD40 signaling is impaired in L. major-infected macrophages and is rescued by a p38MAPK activator establishing a host-protective memory T cell response.
    The Journal of experimental medicine, 2003, Apr-21, Volume: 197, Issue:8

    Topics: Animals; Anisomycin; CD40 Antigens; Cells, Cultured; Enzyme Activation; Enzyme Inhibitors; Gene Expression Regulation; Imidazoles; Leishmania major; Leishmaniasis, Cutaneous; Macrophages, Peritoneal; Mice; Mice, Inbred BALB C; Mitogen-Activated Protein Kinases; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; p38 Mitogen-Activated Protein Kinases; Protein Synthesis Inhibitors; Pyridines; Signal Transduction; Th1 Cells

2003